Global Protein Crystallization & Crystallography Market is valued approximately USD 1 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.9 % over the forecast period 2020-2027. Protein crystallization is a process to develop protein crystals, that are used for industrial or scientific purposes, such as X-Ray Crystallography. Increasing R&D by pharmaceuticals and biotechnology companies. Crystallography and protein crystallization is used for scientific and manufacturing purposes and for making small protein crystals. Protein crystallization process is usually used in water, as proteins functions in aqueous surroundings. This method build up well-ordered protein crystals that surmount the inbuilt feebleness of protein molecules. The global Protein Crystallization & Crystallography market is facing challenges due to the coronavirus pandemic as government asked to work from home and various organizations are temporary shutdown. The increasing demand for protein therapeutics, rising technological advancements and increasing focus on miniaturization are the few factors responsible for growth of the market over the forecast period. Furthermore, the rising advancements and other strategic alliance by market key players will create a lucrative demand for this market. For instance: in 2018, Bruker Corporation launched D8 DISCOVER Plus X-ray Diffraction (XRD). Its specifications are Phase Identification, Quantitative Analysis, Crystal structure determination, PDF analysis (total scattering) and many more. Whereas, high cost of instruments is the major factor restraining the growth of global Protein Crystallization & Crystallography market during the forecast period.

The regional analysis of global Protein Crystallization & Crystallography market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Bruker Corporation
Rigaku Corporation
Hampton Research
Agilent Technologies
Corning Incorporated
Tecan Group
SARomics Biostructures
Spectris Plc
Charles River Laboratories
Thermo Fischer Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Technology:
X-ray Crystallography
Nuclear Magnetic Resonance (NMR) Spectroscopy
Cryo-electron Microscopy
Small-angle X-ray Scattering (SAXS)

by Product & Services:
Reagents Kits/Screens
Software & Services

By End-User:
Pharmaceutical Companies
Research & Government Institutes
Biotechnology Companies

By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Protein Crystallization & Crystallography Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers